Morgan Stanley Cuts Weigao Group Target to HK$4.5, Maintains 'Market Perform' Rating

Deep News07-26

Morgan Stanley has released a research report indicating adjustments to its outlook for WEIGAO GROUP (01066).

The investment bank has lowered its revenue forecasts for the company for the 2026 to 2028 period by 1% to 2% to reflect ongoing headwinds from Volume-Based Procurement (VBP) and increased competition in the conventional consumables business, as well as the impact of recent policies on the orthopedics segment. As a result, overall revenue is expected to see only low single-digit growth.

Morgan Stanley has also reduced its earnings per share (EPS) estimates for WEIGAO GROUP for the 2026 to 2028 fiscal years by 11.8%, 12.6%, and 13.5%, respectively. Consequently, the price target has been slashed from HK$5.2 to HK$4.5, while the broker continues to assign a "Market Perform" rating to the stock.

The report notes that these revisions account for the challenging market environment and policy impacts currently facing the company's core business segments.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment